Jeil Pharma Holdings Inc

KOSE:A002620 주식 보고서

시가총액: ₩131.4b

Jeil Pharma Holdings 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Seung-Soo Han

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권66.0%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

Mar 25
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

Feb 27
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jan 23
What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Dec 28
Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

Nov 23
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

CEO

Seung-Soo Han (77 yo)

no data

테뉴어

Seung Soo Han serves the Chairman of the Board and Chief Executive Officer of Jeil Pharma Holdings Inc (formerly known as Jeil Pharmaceutical Co., Ltd.)